OR WAIT null SECS
MedClean Technologies, Inc., a provider of on-site technology for the treatment and disposal of medical waste and the destruction of confidential documents and related media, announces that it has formed a co-marketing agreement with Covidien, a global healthcare products company.
With this relationship, Covidien's national sales force for SharpSafety products will promote MedClean products and services in a complimentary manner to MedClean's existing distributor sales force. As a result of this relationship with Covidien, and the MedAssets relationships already in place, MedClean will have multiple sales professionals promoting the company in nearly every hospital in the U.S. In addition, MedClean will sell and distribute Covidien's market-leading sharps and waste containers.
"This relationship is our largest co-promotion arrangement to date, broadening the exposure of our products and connecting MedClean with nearly every hospital in the country," says David Laky, MedClean's President and CEO. "One of the goals of this co- promotion relationship is to ensure the market is educated about disposable sharps versus reusable sharps and the benefits, through safety and expense reduction, that disposable sharps programs provide to healthcare facilities. We estimate the market for sharps containers to exceed $280million annually, and capturing a significant share of this market is a priority for both companies. We are excited to collaborate with Covidien and look forward to a long and mutually productive relationship."
MedClean now has approximately 98 sales professionals in 50 states plus Canada promoting the company's Technology enabled Solutions (TeS) for the treatment and disposal of medical waste and the destruction of confidential documents and related media.
"The extended sales cycle and the process for educating sales professionals on the benefits and details of our systems takes about six to nine months," Laky adds. "We continue to see distributors ramping up their lead generation efforts over this time frame, and as such we believe we will see an acceleration of our sales in the coming quarters due to the many relationships we have brought on board in the last year."